Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781726 · ClinicalTrials.gov registry record · Phase 4
Multi-center Study to Transplant Hepatitis-C Infected Kidneys
A Phase 4 study, sponsored by Raymond Chung.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT03781726: Completed Phase 4 study, sponsored by Raymond Chung.
NCT03781726 is a Phase 4 study that has completed, run by Raymond Chung. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03781726, a Phase 4 study, has completed, sponsored by Raymond Chung.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Open label multi center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.
Primary Outcome
HCV RNA \< LLOQ 12 weeks after the last actual dose of G/P
Interventions
- DRUG glecaprevir/pibrentasvir treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 4 |
What the finished NCT03781726 record still lists
NCT03781726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which glecaprevir/pibrentasvir treatment is the first listed.
NCT03781726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03781726 about?
NCT03781726 is a clinical study titled "Multi-center Study to Transplant Hepatitis-C Infected Kidneys". Open label multi center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.
What is the current status of trial NCT03781726?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2019-04-10. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03781726?
The interventions under investigation include: glecaprevir/pibrentasvir treatment (DRUG).
Who is sponsoring clinical trial NCT03781726?
This trial is sponsored by Raymond Chung, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03781726's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI